When should I use the HEART (History, ECG, Age, Risk factors, Troponin) score, TIMI (Thrombolysis In Myocardial Infarction) score, and GRACE (Global Registry of Acute Coronary Events) score for risk stratification in patients presenting with chest pain?

Risk Score Selection for Chest Pain Stratification

Use the HEART score (≤3) for initial risk stratification in undifferentiated chest pain patients in the emergency department, while reserving GRACE and TIMI scores specifically for patients with confirmed acute coronary syndrome (ACS). 1

Clinical Context Determines Score Selection

The 2025 ACC/AHA/ACEP guidelines clearly delineate when each score should be applied based on where the patient falls in the diagnostic pathway 1:

HEART Score: First-Line for Undifferentiated Chest Pain

• Apply at initial ED presentation when ACS is suspected but not yet confirmed
• Use in the "observation zone" for intermediate-risk patients with troponin values between limit of quantification and 99th percentile 2
• Modified HEART score ≤3 identifies patients safe for discharge with negative predictive value >99% for major adverse cardiac events (MACE) 3, 4
• Achieves sensitivity of 97-99.5% for 30-day MACE while identifying 34-54% of patients suitable for early discharge 4, 5

GRACE and TIMI: For Established ACS Only

• Do not use as diagnostic tools - these stratify risk only after ACS is suspected or confirmed 1
• GRACE Risk Score 2.0 predicts in-hospital, 6-month, 1-year, and 3-year death or death/MI in patients with confirmed ACS 1
• TIMI scores predict 14-day outcomes in NSTE-ACS and 30-day mortality in STEMI 1
• GRACE demonstrates superior performance to physician judgment for predicting death/MI in established STEMI or intermediate-risk NSTE-ACS 1

Algorithmic Approach

Step 1: Initial Presentation with Chest Pain

• Calculate HEART score using: History, ECG, Age, Risk factors, and Troponin
• HEART ≤3 with non-ischemic ECG → Safe for discharge with outpatient follow-up 2, 3
• HEART >3 → Proceed to serial troponin testing and further evaluation

Step 2: If ACS Confirmed or Highly Suspected

• Switch to GRACE or TIMI scores for prognostication
• GRACE preferred for comprehensive risk assessment across ACS spectrum 1
• TIMI useful for specific populations (NSTE-ACS vs STEMI) with validated outcome timeframes 1

Key Performance Differences

The evidence reveals critical distinctions in discriminative ability:

HEART Score Advantages:

• Highest area under curve (AUC 0.87-0.93) for 30-day MACE in undifferentiated chest pain 4, 6
• Superior negative predictive value (99.5-99.8%) at low-risk threshold 3, 4
• Identifies 3-4 times more patients as low-risk compared to TIMI score (34-54% vs 12-26%) 4, 5

GRACE Score Advantages:

• Better calibrated for established ACS populations 1
• Validated for longer-term outcomes (up to 3 years) 1
• Superior to TIMI for overall ACS risk stratification when diagnosis confirmed 7

TIMI Score Limitations:

• Very conservative - TIMI=0 identifies only 12-26% as low-risk 4, 5
• Better suited for confirmed ACS rather than rule-out scenarios 1
• When TIMI ≤1 used with high-sensitivity troponin, achieves excellent sensitivity but poor specificity 3

Critical Caveats

Timing Matters:

• HEART score requires troponin obtained ≥3 hours after symptom onset when using single measurement 2
• For very early presenters (<3 hours), serial testing mandatory regardless of initial score 3

Troponin Assay Dependency:

• Performance varies between high-sensitivity troponin T vs I assays 8
• Know your institution's specific assay characteristics (limit of quantification, 99th percentile, sex-specific cutoffs) 2, 1
• HEART score with contemporary (non-high-sensitivity) troponin still achieves NPV ≥99.5% 4

Population Considerations:

• Most validation studies exclude patients with ischemic ECG changes - these patients require immediate ACS management regardless of scores 2
• Scores should not override clinical judgment in obviously high-risk presentations 1

Common Pitfalls to Avoid

1. Don't use GRACE/TIMI for initial ED triage - they lack sensitivity for ruling out ACS in undifferentiated chest pain 1

2. Don't discharge based on troponin alone - even with high-sensitivity assays, clinical context via HEART score improves safety 2, 3

3. Don't apply HEART score to confirmed MI patients - switch to GRACE/TIMI once diagnosis established 1

4. Don't ignore intermediate troponin values - this "observation zone" specifically requires modified HEART score or EDACS for further stratification 2